W912LQ-16-T-0001-0004.pdf

AMENDMENT OF SOLICITATION/MODIFICATION OF CONTRACT

Except as provided herein, all terms and conditions of the document referenced in Item 9A or 10A, as heretofore changed, remains unchanged and in full force and effect.

15A. NAME AND TITLE OF SIGNER (Type or print)

30-105-04EXCEPTION TO SF 30

APPROVED BY OIRM 11-84

STANDARD FORM 30 (Rev. 10-83) Prescribed by GSA

FAR (48 CFR) 53.243

a. The purpose of this amendment is to answ er questions posed by interested vendors and revise the descriptions of line items 0006, 0007, 0008, 0010, 0011, 1006, 1007, 1008, 1010, 1011.

b. The time and date for receipt of quotes is not extended.

c. See summary of changes.

1. CONTRACT ID CODE PAGE OF PAGES

J 1 6

16A. NAME AND TITLE OF CONTRACTING OFFICER (Type or print)

16C. DATE SIGNED

BY 20-Jan-2016

16B. UNITED STATES OF AMERICA15C. DATE SIGNED15B. CONTRACTOR/OFFEROR

(Signature of Contracting Officer)(Signature of person authorized to sign)

8. NAME AND ADDRESS OF CONTRACTOR (No., Street, County, State and Zip Code) X W912LQ-16-T-0001

X 9B. DATED (SEE ITEM 11)

02-Dec-2015

10B. DATED (SEE ITEM 13)

9A. AMENDMENT OF SOLICITATION NO.

11. THIS ITEM ONLY APPLIES TO AMENDMENTS OF SOLICITATIONS

X The above numbered solicitation is amended as set forth in Item 14. The hour and date specified for receipt of Offer is extended, X is not extended.

Offer must acknowledge receipt of this amendment prior to the hour and date specified in the solicitation or as amended by one of the following methods:

(a) By completing Items 8 and 15, and returning 1 copies of the amendment; (b) By acknowledging receipt of this amendment on each copy of the offer submitted;

or (c) By separate letter or telegram which includes a reference to the solicitation and amendment numbers. FAILURE OF YOUR ACKNOWLEDGMENT TO BE RECEIVED AT THE PLACE DESIGNATED FOR THE RECEIPT OF OFFERS PRIOR TO THE HOUR AND DATE SPECIFIED MAY RESULT IN

REJECTION OF YOUR OFFER. If by virtue of this amendment you desire to change an offer already submitted, such change may be made by telegram or letter, provided each telegram or letter makes reference to the solicitation and this amendment, and is received prior to the opening hour and date specified.

12. ACCOUNTING AND APPROPRIATION DATA (If required)

13. THIS ITEM APPLIES ONLY TO MODIFICATIONS OF CONTRACTS/ORDERS.

IT MODIFIES THE CONTRACT/ORDER NO. AS DESCRIBED IN ITEM 14.

A. THIS CHANGE ORDER IS ISSUED PURSUANT TO: (Specify authority) THE CHANGES SET FORTH IN ITEM 14 ARE MADE IN THE

CONTRACT ORDER NO. IN ITEM 10A.

B. THE ABOVE NUMBERED CONTRACT/ORDER IS MODIFIED TO REFLECT THE ADMINISTRATIVE CHANGES (such as changes in paying office, appropriation date, etc.) SET FORTH IN ITEM 14, PURSUANT TO THE AUTHORITY OF FAR 43.103(B).

C. THIS SUPPLEMENTAL AGREEMENT IS ENTERED INTO PURSUANT TO AUTHORITY OF:

D. OTHER (Specify type of modification and authority)

E. IMPORTANT: Contractor is not, is required to sign this document and return copies to the issuing office.

14. DESCRIPTION OF AMENDMENT/MODIFICATION (Organized by UCF section headings, including solicitation/contract subject matter where feasible.)

10A. MOD. OF CONTRACT/ORDER NO.

2. AMENDMENT/MODIFICATION NO. 5. PROJECT NO.(If applicable)

6. ISSUED BY

3. EFFECTIVE DATE

20-Jan-2016

CODE

VAPFO-P

USPFO FOR VIRGINIA,

BLDG 316

FORT PICKETT

BLACKSTONE VA 23824-6316

W912LQ 7. ADMINISTERED BY (If other than item 6)

4. REQUISITION/PURCHASE REQ. NO.

CODE

See Item 6

FACILITY CODECODE

EMAIL:TEL:

W912LQ-16-T-0001

SECTION SF 30 BLOCK 14 CONTINUATION PAGE

SUMMARY OF CHANGES

SECTION SF 1449 - CONTINUATION SHEET

SUPPLIES OR SERVICES AND PRICES

CLIN 0006

The CLIN description has changed from Varicella Titer (quantitative) to Varicella Titer.

The CLIN extended description has changed from:

Varicella Titer (quantitative) - VZV Antibodies, IgG

To:

Varicella Titer - VZV Antibodies, IgGQualitive or Quantative is acceptable. Interested vendors must indicate which is being priced. ____________________.

CLIN 0007

The CLIN description has changed from MMR Titer (quantitative) to MMR Titer.

The CLIN extended description has changed from:

MMR Titer (quantitative)

To:

MMR TiterQualitive or Quantative is acceptable. Interested vendors must indicate which is being priced.

CLIN 0008

The CLIN extended description has changed from:

Multi-chem to include Fasting Glucose, & HDL (HDL, LDL, HDL/Cholesterol Ratio) (Chem 12)

To:

Multi-chem to include Glucose, Sodium, Potassium, CO2, Chloride, BUN, Creatinine, Total Cholesterol, HDL, LDL.

CLIN 0010

Fecal Occult Blood Cards (kit)

To:

Fecal Occult Blood Cards (kit)While the guiac based test is preferred, the Occult Blood, Fecal Immunoassay is an acceptable alternative. Interested vendors must indicate which is being priced. ____________________.

CLIN 0011

Chem (7)

Chem (7) to include Glucose, Sodium, Potassium, CO2, Chloride, BUN, Creatinine.

CLIN 1006

The CLIN description has changed from Varicella Titer (quantitative) to Varicella Titer.

The CLIN extended description has changed from:

Varicella Titer (quantitative) - VZV Antibodies, IgG

To:

Varicella Titer - VZV Antibodies, IgGQualitive or Quantative is acceptable. Interested vendors must indicate which is being priced. ____________________.

CLIN 1007

The CLIN description has changed from MMR Titer (quantitative) to MMR Titer.

The CLIN extended description has changed from:

MMR Titer (quantitative)

To:

MMR TiterQualitive or Quantative is acceptable. Interested vendors must indicate which is being priced.

CLIN 1008

Multi-chem to include Fasting Glucose, & HDL (HDL, LDL, HDL/Cholesterol Ratio) (Chem 12)

To:

Multi-chem to include Glucose, Sodium, Potassium, CO2, Chloride, BUN, Creatinine, Total Cholesterol, HDL, LDL.

CLIN 1010

The CLIN description has changed from Fecal Occult Blood Cards (kit) to Fecal Occult Blood.

The CLIN extended description has changed from:

Fecal Occult Blood Cards (kit)

To:

Fecal Occult BloodWhile the guiac based test is preferred, the Occult Blood, Fecal Immunoassay is an acceptable alternative. Interested vendors must indicate which is being priced. ____________________.

CLIN 1011

Chem (7)

Chem (7) to include Glucose, Sodium, Potassium, CO2, Chloride, BUN, Creatinine.

The following have been modified:

QUESTIONS AND ANSWERS

AMENDMENT 0001

Q1: What firm or company is currently providing these testing services to the Virginia National Guard?

A1: Currently there is not an existing contract through the Virginia National Guard USPFO. In previous years, LabCorp has provided services either through Government Purchase Card (GPC) procurements or other contracts.

Q2: What electronic delivery method is currently used to receive results? e.g. An electronic data interface between a lab testing vendor and a National Guard electronic medical records (EMR) system; fax; other?

A2: Currently, there is no interface between the Virginia National Guard's electronic medical system and a contractor. The Virginia National Guard has a secure fax which is HIPAA compliant and has been used for electronic delivery of results.

Q3: Are there any security checkpoints or steps that must be followed in order to take possession of the patient specimens from the military facilities referenced in the document?

A3: Paragraph 5. of the Performance Work Statement (PWS) addresses security requirements. At individual locations, proper identification (i.e., driver's license) is required for access. In addition, at the State Military Reservation at Virginia Beach, the Army Aviation Support Facility in Sandston and at Fort Belvoir, the identity of the driver who will secure the labs is required prior to arrival.

Q4: I am unfamiliar with the CMR application process and reporting requirements. Can you please elaborate on how this would work for a commercial reference laboratory?

A4: All contractors providing a service to the Department of Defense (DoD) must report all labor hours required for performance of contracted services. For laboratory testing services, this may include labor for the driver and labor for individuals at the laboratory facility performing tests, analysis, and/or reporting of results. Additional information regarding eCMRA requirements, including reporting requirements can be found at https://cmra.army.mil. To view the User Manuals, Frequently Asked Questions (FAQ) and Glossary, click on the hyperlink under Help Resources on the right side of the home page. This will display the Glossary. To the left of the Glossary, under Contents, there are hyperlinks to CMRA Overview and FAQ.

Q5: Will you consider use of existing DoD contracts or Federal Supply Schedules (FSS) for purposes of award?

A5: This solicitation is being issued using full and open competition procedures resulting in a indefinite delivery type contract. While pricing at or better than those on existing DoD contractor or Federal Supply Schedules (FSS) can be offered, the terms and conditions of th is solicitation, not an existing contract, will be incorporated into the resulting award.

Q6: Does the laboratory need to be physically located in Virginia?

A6: No. Regardless of physical location, the contractor will be responsible for meeting all contract requirements to include credentialing and time schedules for collection of samples and delivery of results.

Q7: How or will the government monitor accuracy of test results (i.e. correct/accurate lab test performed for the correct individual, accurate reporting, quality of the reports, etc.)?

A7: The requiring activity will manage a roster of lab reports requested with copies of the requisition forms. A quality control will be performed by comparing lab results with the order forms.

AMENDMENT 0003

QUESTION: Does this contract allow for subcontracting of services?

ANSWER: Yes.

AMENDMENT 0004

Q1. Please list all the components included in Item # 0008 Multi-Chem.

A1. Glucose, Sodium, Potassium, CO2, Chloride, BUN, Creatinine, Total Cholesterol, HDL, LDL

Q2. If a laboratory does not offer fecal occult blood cards (Item #0010), but instead offers an Immunoassay test to detect human hemoglobin in fecal specimens, will that be an acceptable alternative?

A2. While the guiac based test is preferred, the occult blood, fecal, immunoassay is an acceptable alternative.

Q3. Please list all the components included in Item # 0011 Chem (7).

A3. Glucose, Sodium, Potassium, CO2, Chloride, BUN, Creatinine

Q4. Does the Solicitation posted on 12/31/2015 supersede the prior documents? In other words, will the completion of the document posted on 12/31/15 and subsequent amendment(s) be considered a complete proposal, or do the prior Solicitation Documents need be printed, completed, signed and returned along with the document posted on 12/31/15?

A4. Yes. Amendement 0002 is a conformed document incorporating the original solicitation, amendment 0001 and amendment 0002. The conformed solicitation document posted on December 31, 2015 supercedes the documents posted on December 2 and 9, 2015.

Q5. There is a requirement that the contractor brief all employees (and associated sub-contractor employees) on the local iWATCH program (item 5.7 on page 67 of 71). Our company has a very large number of employees, the vast majority of which will have nothing to do with work being performed under this solicitation. Will you please revise or re-consider this requirement?

A5. Employees performing work under a Virginia National Guard contract are required to adhere to the iWatch Training. Paragraph 5.7 is hereby changed to read as follows:

The contractor and all associated sub-contractors shall brief all employees performing work under this contract on the local iWATCH program. This locally developed training will be used to inform employees of the types of behavior to watch for and instruct employees to report suspicious activity to the COR. This training shall be completed within 90 calendar days of contract award and within 60 calendar days of new employees commencing performance with the results reported to the COR within 100 calendar days after contract award.

The following have been deleted:

QUESTIONS AND ANSWERS

(End of Summary of Changes)